CliffBio
small molecule

SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE

PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM

Loss of exclusivity—loss of exclusivity
CompanyGenus Lifesciences Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameSULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE
Active ingredientPREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM
StrengthEQ 0.23% PHOSPHATE;10%
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalMay 1993
Marketing statusDISCN

More from Genus Lifesciences Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE patent cliff — loss of exclusivity — | CliffBio